BREAST CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
phenotype |
|
Finding
|
1
|
|
0.300 |
definitive |
1.000 |
10 |
|
1994 |
2005 |
OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
phenotype |
|
Finding
|
1
|
|
0.300 |
definitive |
1.000 |
10 |
|
1994 |
2005 |
FANCONI ANEMIA, COMPLEMENTATION GROUP S
|
disease |
|
Disease or Syndrome
|
1
|
28
|
0.700 |
definitive |
1.000 |
7 |
28
|
2013 |
2019 |
PANCREATIC CANCER, SUSCEPTIBILITY TO, 4
|
disease |
|
Finding
|
1
|
22
|
0.400 |
None |
1.000 |
2 |
22
|
2003 |
2018 |
Mucocele of appendix
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Breast Microglandular Adenosis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
PANCREATIC CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Occult carcinoma
|
disease |
|
Neoplastic Process
|
2
|
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2018 |
Contralateral Breast Carcinoma
|
disease |
|
Neoplastic Process
|
2
|
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2006 |
Fallopian Tube Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Primary serous papillary carcinoma of peritoneum
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
FANCONI ANEMIA, COMPLEMENTATION GROUP E
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Usual ductal hyperplasia of breast
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hereditary site-specific ovarian cancer syndrome
|
disease |
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Ovarian Serous Surface Papillary Adenocarcinoma
|
disease |
|
Neoplastic Process
|
2
|
2
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
disease |
|
Finding
|
2
|
2633
|
0.100 |
None |
|
0 |
1
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
3
|
2277
|
0.700 |
definitive |
1.000 |
465 |
2258
|
1976 |
2019 |
Atypical medullary carcinoma
|
disease |
|
Neoplastic Process
|
3
|
|
0.040 |
None |
1.000 |
4 |
|
1998 |
2006 |
Malignant phyllodes tumor of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
3
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Carcinoma in situ of fallopian tube
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
FANCONI ANEMIA, COMPLEMENTATION GROUP J
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
3
|
141
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Pelvic Cancer
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2012 |
Climacteric discomfort
|
phenotype |
|
Sign or Symptom
|
4
|
|
0.020 |
None |
0.500 |
2 |
|
2018 |
2019 |
Malignant neoplasm of abdomen
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Ovarian Cystadenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |